Scalper1 News
Medical-device maker Boston Scientific (BSX) got upgrades from both Morgan Stanley and Oppenheimer Monday, sending the stock up nearly 3% to a four-year high in afternoon trading on the stock market today. Morgan Stanley’s David Lewis rated the stock overweight, citing the strength of the company’s pipeline and its opportunities for margin expansion. “Over the past several years, the company has targeted investments across several markets to Scalper1 News
Scalper1 News